Biotech IPOs are cautiously returning, but Big Pharma's aggressive M&A for pipeline replenishment creates intense market competition.
Read More

Biotech IPOs are cautiously returning, but Big Pharma's aggressive M&A for pipeline replenishment creates intense market competition.
Read More
Discover how microgravity in low Earth orbit is revolutionizing pharmaceutical drug development, accelerating protein crystallization and tissue engineering.
Read More